Vector Design for Improved DNA Vaccine Efficacy, Safety and Production

  • Williams J
N/ACitations
Citations of this article
276Readers
Mendeley users who have this article in their library.

Abstract

DNA vaccination is a disruptive technology that offers the promise of a new rapidly deployed vaccination platform to treat human and animal disease with gene-based materials. Innovations such as electroporation, needle free jet delivery and lipid-based carriers increase transgene expression and immunogenicity through more effective gene delivery. This review summarizes complementary vector design innovations that, when combined with leading delivery platforms, further enhance DNA vaccine performance. These next generation vectors also address potential safety issues such as antibiotic selection, and increase plasmid manufacturing quality and yield in exemplary fermentation production processes. Application of optimized constructs in combination with improved delivery platforms tangibly improves the prospect of successful application of DNA vaccination as prophylactic vaccines for diverse human infectious disease targets or as therapeutic vaccines for cancer and allergy.

Cite

CITATION STYLE

APA

Williams, J. (2013). Vector Design for Improved DNA Vaccine Efficacy, Safety and Production. Vaccines, 1(3), 225–249. https://doi.org/10.3390/vaccines1030225

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free